Atlas Trials

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

Clinical trial NCT02450708 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02450708
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Leukemia
Start date
2015-05-01
Primary completion
2027-05-01
Enrollment
511

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.